• OPEN AN ACCOUNT
Indian Indices
Sensex
76,515.43 362.57
( 0.48%)
Global Indices
Nasdaq
53,423.66 -283.45
(-0.53%)
Dow Jones
7,737.34 -31.37
(-0.40%)
Hang Seng
65,002.68 788.20
(1.23%)
Nikkei 225
10,828.70 -2.82
(-0.03%)
Forex
USD-INR
94.48 -0.24
(-0.26%)
EUR-INR
109.71 0.00
(0.00%)
GBP-INR
127.63 -0.19
(-0.15%)
JPY-INR
0.60 0.01
(1.60%)

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
532331
INE031B01049
337.9869392
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AJANTPHARM
42.98
43291.43
EPS(TTM)
Face Value()
Div & Yield %
80.61
2
0.81
 

R R Financial Consultants consolidated net profit declines 96.13% in the March 2026 quarter
Jun 01,2026
Net profit of R R Financial Consultants declined 96.13% to Rs 0.07 crore in the quarter ended March 2026 as against Rs 1.81 crore during the previous quarter ended March 2025. Sales declined 32.44% to Rs 6.29 crore in the quarter ended March 2026 as against Rs 9.31 crore during the previous quarter ended March 2025.

For the full year,net profit rose 186.00% to Rs 7.15 crore in the year ended March 2026 as against Rs 2.50 crore during the previous year ended March 2025. Sales rose 25.48% to Rs 33.34 crore in the year ended March 2026 as against Rs 26.57 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales6.299.31 -32 33.3426.57 25
OPM %11.7630.61 -31.9715.58 -
PBDT0.832.90 -71 10.584.00 165
PBT0.772.85 -73 10.393.82 172
NP0.071.81 -96 7.152.50 186